CIL Isotope Separations, LLCJanuary 25, 2022

FDA 483 - CIL Isotope Separations, LLC - January 25, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CIL Isotope Separations, LLC

Record Details

CIL Isotope Separations, LLC in Xenia, OH, a finished API manufacturer, was cited for significant deficiencies related to equipment and material suitability, environmental controls, and facility qualification during an FDA inspection. The inspection revealed issues including an unvalidated water system with high bioburden, inadequate differential pressure controls leading to air contamination, and an unqualified HVAC system, all impacting the production of Urea-13C. This is a repeat observation regarding equipment and material suitability.

Company: CIL Isotope Separations, LLC
Inspection Date: January 25, 2022
Product Type: Drugs
Office: Cincinnati District Office
People: Wen Ning Chan (Mathematical statistician)
Lauren N. Howard (Drug Specialist)

Open in Dashboard

ID · 0b5b94cd-d35c-4baf-82f0-258214724262